Bonella Ramsay co-chairs DLA Piper's Global Life Sciences Sector. As an IP and Life Science law specialist, she advises clients on IP strategy and commercialisation, complex partnering, JV and collaboration agreements and a range of clinical and commercial agreements spanning the life cycle of medicinal products, medical devices and diagnostics; from technology transfer and licensing arrangements, sponsored research and clinical trial agreements, outsourcing of regulated functions/services, supply chain arrangements, market access, public procurement/tenders and co-promotion agreements.
Bonella also advises clients on pharma and medical device/IVD regulatory issues, including marketing authorisation proceedings, orphan drug applications, clinical trials and GCP, transparency issues, data privacy, serialisation of medicines and software as medical devices. She supports clients on a wider range of compliance issues with a particular focus on advertising and promotion of medicines and devices and compliance with codes of conduct.
More recently, Bonella has also focused on Brexit, AI in healthcare and genomics, speaking widely on these topics.
Pharma and Medical Device Regulation
Research, Clinical Trials and Transparency
Advertising/Promotion of Medicines and Devices
Life Science Collaboration and Partnering Arrangements
Life Science Supply Chain
AI in Healthcare